Quotient reagents drop-ship
Ended Awarded Last action
- Contract number
- N6847022F9800
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $51,154
Award facts
- Contract value 100% obligated
- $51,153.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60607, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $25,577 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $25,577 | |
| Original award | $0 |
About this award
This is a delivery order contract awarded by the Defense Health Agency (DHA) to Alba Bioscience, Inc., a for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract is for the delivery of QUOTIENT REAGENTS and has a ceiling value of $51,153.68. It is not designated as a set-aside contract.
The contract is part of a larger Indefinite Delivery Vehicle (IDV) under the General Services Administration (GSA) Schedule 65-VII for in vitro diagnostics, reagents, and tests. Specifically, Alba Bioscience holds two significant federal contract IDVs, both Blanket Purchase Agreements (BPAs) with the Department of Veterans Affairs (VA). The first is a single-award BPA with Veterans Integrated Service Network 10, valued at $109,420.35 and extending through September 30, 2029, focused on red blood cell reagents. The second is a multiple-award BPA with Veterans Integrated Service Network 1, valued at $30,000 and running through September 14, 2028, for blood bank reagents.
Quick answers
Who was awarded contract N6847022F9800?
N6847022F9800 was awarded to Alba Bioscience, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on October 1, 2022.
How much is contract N6847022F9800 worth?
The government has obligated $51,154 on N6847022F9800.
Which agency awarded contract N6847022F9800?
Bureau of Medicine and Surgery (Department of the Navy) awarded N6847022F9800, with funding from Defense Health Agency (Department of Defense).
Is contract N6847022F9800 an order under another contract?
Yes. N6847022F9800 is a delivery order under 36F79721D0259, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract N6847022F9800 competed?
The extent of competition for N6847022F9800 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award